Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study will be conducted upon the patients with fatty liver disease. Patients who will be
diagnosed as a case of fatty liver disease by ultrasound with raised liver enzyme (ALT) will
be primarily selected for the study. A total number of 70 patients will be randomly selected
for the study that will also be divided into two groups for the study purpose. The patients
will be informed about the details of the study. After getting the detail information those
who will give informed written consent will be finally included in the study. One group of
patients will be treated by both life style modification and Obeticholic acid. Another group
of patients by only life style modification. After 3 months of treatment the two groups will
be compared of improvement of fatty liver disease and liver enzyme by improvement of
fibroscan with CAP value as well as improvement of ALT value.